Correlation Between Enliven Therapeutics and Carmell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Carmell Therapeutics, you can compare the effects of market volatilities on Enliven Therapeutics and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Carmell Therapeutics.
Diversification Opportunities for Enliven Therapeutics and Carmell Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Enliven and Carmell is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Carmell Therapeutics go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Carmell Therapeutics
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.37 times more return on investment than Carmell Therapeutics. However, Enliven Therapeutics is 2.69 times less risky than Carmell Therapeutics. It trades about -0.16 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 2,839 in Enliven Therapeutics on August 31, 2024 and sell it today you would lose (298.00) from holding Enliven Therapeutics or give up 10.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Carmell Therapeutics
Performance |
| Timeline |
| Enliven Therapeutics |
| Carmell Therapeutics |
Enliven Therapeutics and Carmell Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Carmell Therapeutics
The main advantage of trading using opposite Enliven Therapeutics and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.| Enliven Therapeutics vs. Cue Biopharma | Enliven Therapeutics vs. Eliem Therapeutics | Enliven Therapeutics vs. Inhibrx | Enliven Therapeutics vs. Molecular Partners AG |
| Carmell Therapeutics vs. ZyVersa Therapeutics | Carmell Therapeutics vs. Sonnet Biotherapeutics Holdings | Carmell Therapeutics vs. Revelation Biosciences | Carmell Therapeutics vs. Quoin Pharmaceuticals Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |